Hyperscale Data, Inc. (NYSE:GPUS), an artificial intelligence ("AI") data center company anchored by Bitcoin ("Hyperscale Data" or the...
Intel stock falls 4% pre-market amid a broader tech pullback. Get the key technical levels to watch for INTC.
Wells Fargo analyst Alec Brondolo maintains Snap (NYSE:SNAP) with a Equal-Weight and lowers the price target from $7 to $5.
Ciena benefits from unprecedented demand for optical connectivity, driving revenue acceleration and expanding backlog. Learn why CIEN stock is a buy.
Magnetic fusion start-up Proxima Fusion has raised €411 million ($469.69 million) from investors including Alphabet's Google and German utility RWE ...
QTEX shares gained after QTREX Quantum announced deployment of its AME system at a leading U.S. government research laboratory.
Visa (V) rated Hold as macro risks rise despite strong Q2 results.
The company's inclusion in the S&P SmallCap 600 marks an important milestone for Centrus as it works to restore America's domestic uranium...
Wells Fargo analyst Alec Brondolo maintains Take-Two Interactive (NASDAQ:TTWO) with a Overweight and raises the price target from $287 to $289.
Solstice shares drop 15% on $14.5B Element Solutions deal; see leverage, synergy and valuation risks behind âbuy the dip.â Read why SOLS stock is ...
B of A Securities analyst Jessica Reif Cohen maintains iHeartMedia (NASDAQ:IHRT) with a Neutral and lowers the price target from $6 to $5.
Trading Records for Second Quarter 2026Select June 2026 Highlights* (See tables 1-1C and table 2)Total credit trading volumes showed continued strengt...
Wells Fargo analyst Alec Brondolo maintains AppLovin (NASDAQ:APP) with a Overweight and raises the price target from $571 to $575.
Wells Fargo analyst Steven Cahall maintains Comcast (NASDAQ:CMCSA) with a Underweight and lowers the price target from $29 to $28.
Wolfe Research analyst Rudy Li initiates coverage on LB Pharmaceuticals (NASDAQ:LBRX) with a Outperform rating and announces Price Target of $45.
Wells Fargo analyst Steven Cahall maintains Charter Communications (NASDAQ:CHTR) with a Underweight and lowers the price target from $170 to $160.
New 6-month data supports COMP360’s potential to establish a new standard of care in TRDData from positive COMP006 Phase 3 trial demonstrates durable ...
Benchmark analyst Robert Wasserman upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) from Hold to Buy and announces $185 price target.
Solstice (SOLS) stock edges up premarket after a 15% plunge on its $14.5B Element Solutions buyout. Get the latest technicals.
Parsons has been awarded a three-year contract to provide program management, construction management, and construction supervision for the Lusail Cit...
Loading...